Sector
RealtyOpen
₹99.79Prev. Close
₹99.79Turnover(Lac.)
₹273.07Day's High
₹102.15Day's Low
₹98.152 Week's High
₹16952 Week's Low
₹84.25Book Value
₹36.14Face Value
₹2Mkt Cap (₹ Cr.)
2,569.62P/E
18.35EPS
5.44Divi. Yield
2.4Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 51.36 | 51.36 | 51.36 | 51.36 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 757.4 | 777.63 | 962.49 | 775.46 |
Net Worth | 808.76 | 828.99 | 1,013.85 | 826.82 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 72.3 | 73.68 | 125.29 | 147.16 |
yoy growth (%) | -1.88 | -41.18 | -14.85 | 15.39 |
Raw materials | -9.38 | -31.43 | -47.95 | -42.15 |
As % of sales | 12.97 | 42.65 | 38.27 | 28.64 |
Employee costs | -22.59 | -20.78 | -20.74 | -22.83 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 16.51 | 93.68 | 44.17 | 32.44 |
Depreciation | -3.91 | -3.22 | -3.77 | -5.08 |
Tax paid | -3.15 | -0.13 | -2.39 | 0.85 |
Working capital | -37.75 | 55.84 | -10.43 | -55.94 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -1.88 | -41.18 | -14.85 | 15.39 |
Op profit growth | 188.45 | -66.5 | 65.31 | 9.72 |
EBIT growth | -82.13 | 111.89 | 36.02 | 13.73 |
Net profit growth | -85.71 | 123.92 | 51.98 | 11.19 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 157.49 | 127.24 | 78.22 | 73.52 | 73.93 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 157.49 | 127.24 | 78.22 | 73.52 | 73.93 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 54.77 | 64.26 | 89.18 | 10.27 | 93.4 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
DLF Ltd DLF | 663.1 | 341.24 | 1,63,865.63 | -166.09 | 0.76 | 936.74 | 113.2 |
Macrotech Developers Ltd LODHA | 1,157.2 | 59.1 | 1,15,488.55 | 564.7 | 0.19 | 3,485.3 | 172.64 |
Godrej Properties Ltd GODREJPROP | 2,041.45 | 64.8 | 61,518.52 | 34.85 | 0 | 184.99 | 571.46 |
Phoenix Mills Ltd PHOENIXLTD | 1,601.1 | 193.65 | 57,255.58 | 55.81 | 0.16 | 127.46 | 145.73 |
Oberoi Realty Ltd OBEROIRLTY | 1,573.95 | 26.68 | 57,243.72 | 536.53 | 0.25 | 1,276.69 | 377.22 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Chirayu R Amin
Managing Director & CEO
Malika C Amin
Non Executive Director
Udit Amin
Independent Director
Sameer Khera
Company Sec. & Compli. Officer
Drigesh Mittal
Independent Director
Rati Desai
Independent Director
Mayank Amin
Independent Director
Girish Hirode
Independent Director
Geeta Goradia
Independent Director
Mayur Jadeja
Independent Director
Sanjeev Shah
Additional Director
Jain Parkash
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Alembic Ltd
Summary
Alembic Limited is one of the Indias most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. The Company operates primarily in three lines of business, manufacture of Bulk Drugs, Real Estate and Power Generation through Windmills and Co-gen Power Plant which is presently used for captive consumption for the operation of the Bulk Drugs Manufacturing plant at Vadodara. The Company is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.The company manufacture pharmaceuticals and chemicals, bulk drugs (penicillin and other antibiotics) and formulations. It works manufacturing facilities at Vadodara in Gujarat and Solan in Himachal Pradesh.Alembic Limited was incorporated in year 1907 with the name Alembic Chemical Works Company Limited in Vadodara to manufacture tinctures and alcohol. They started to manufacture cough syrup, vitamins, tonics and sulphur durgs in 1940. In 1961, they inaugurated the Pencillin Palnt. In 1968, they started to manufacture Streptomycin.In the 1971, they manufactured Erythromycin using expertise from Eli Lilly, USA and in the year 1972, they launched Althrocin, a brand of Erythromycin. In year 1997, Althrocin become top selling brand in India. In the year 2001, they started to manufacture Cephalosporin C. In June 2001, the company formed a wholly owned subsidiary company named Alembic Europe Pvt Ltd in UK.In the year 2005, the company has launched ZERO, a new generation,
Read More
The Alembic Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹100.07 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Alembic Ltd is ₹2569.62 Cr. as of 02 Apr ‘25
The PE and PB ratios of Alembic Ltd is 18.35 and 3.02 as of 02 Apr ‘25
The 52-week high/low is the highest and lowest price at which a Alembic Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Alembic Ltd is ₹84.25 and ₹169 as of 02 Apr ‘25
Alembic Ltd's CAGR for 5 Years at 22.35%, 3 Years at 10.51%, 1 Year at 11.62%, 6 Month at -30.06%, 3 Month at -24.67% and 1 Month at 12.15%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.